The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization.

J Clin Med · 2020 · PMC7408663 · PMID 32635532

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Stress angina was lesser reported after 1 month with significant differences in all tests along (T1 4.1% versus BL 16.3%, p = 0.04) and before the third step, even if with only a positive trend in favor of ranolazine ( Figure 3 ).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.